journal article·2025-06Open access

Nanoparticle-mediated sodium butyrate delivery for repairing hypoxic-ischemic brain injury in premature infants

Jing Zhao, Jun Zhang, Li Hou, Can Yang, Lin Jiang, Daoxin Liang

Abstract

Hypoxic-ischemic encephalopathy of prematurity (HIEP) is a leading cause of acute mortality and chronic neurological injury in premature infants. This study investigates the molecular mechanisms by which magnetic fluorescent nanoparticles loaded with sodium butyrate (MNs@SB) repair HIEP by modulating the Sp1 and TGF-β1 signaling pathways. Untargeted metabolomics analysis revealed significant suppression of the butyrate metabolism pathway in the intestinal tissues of HIEP mice. We synthesized and characterized MNs@SB nanoparticles, with zeta potential and DLS results indicating an average nanoparticle size of approximately 79.89 nm and a zeta potential of -36.87 mV. TEM images confirmed that the nanoparticles formed polymer-coated clusters. MNs@SB demonstrated excellent biocompatibility and stable magnetic targeting behavior. The nanoparticles were delivered to the brain via tail vein injection and magnetic targeting, with focused ultrasound facilitating their diffusion. The results showed that HIEP mice exhibited a significant increase in infarct size and extensive tissue loss, whereas MNs@SB treatment effectively reversed HIEP-induced brain damage, improving both short-term and long-term neurological deficits. Single-cell RNA sequencing and high-throughput transcriptome analysis revealed that MNs@SB promoted brain repair by upregulating neuronal Sp1, activating the TGF-β1 signaling pathway, and inhibiting neuronal apoptosis. In vivo experiments further confirmed that MNs@SB treatment restored SP1 mRNA and protein expression in the brain. Additionally, MNs@SB treatment significantly restored TGF-β1, p-SMAD2, and p-SMAD3 protein expression, indicating activation of the TGF-β1/SMAD2/3 signaling pathway. This study presents a novel nanomedicine therapeutic strategy with potential clinical applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Neonatal and fetal brain pathology · Anesthesia and Neurotoxicity Research · Traumatic Brain Injury and Neurovascular Disturbances

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (82)

Show source-provided references
1. Neonatal encephalopathy: beyond hypoxic-ischemic encephalopathy10.1542/neo.22-3-e148 ↗
2. Mild hypoxic-ischemic encephalopathy (HIE): timing and pattern of MRI brain injury10.1038/s41390-022-02026-7 ↗
4. Clinical targeting of the cerebral oxygen cascade to improve brain oxygenation in patients with hypoxic–ischaemic brain injury after cardiac arrest10.1007/s00134-023-07165-x ↗
5. Drug delivery platforms for neonatal brain injury10.1016/j.jconrel.2020.12.056 ↗
6. Extracellular vesicles from immortalized mesenchymal stromal cells protect against neonatal hypoxic-ischemic brain injury10.1186/s41232-023-00274-6 ↗
7. Neonatal hypoxic-ischemic encephalopathy and hypothermia treatment
8. Association of EEG background and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy receiving hypothermia10.1212/WNL.0000000000207744 ↗
9. Update on mechanisms of the pathophysiology of neonatal encephalopathy10.1016/j.siny.2021.101267 ↗
10. The fate and prospects of stem cell therapy in the treatment of hypoxic–ischemic encephalopathy10.1111/ejn.16040 ↗
11. Clinical seizures and unfavorable brain MRI patterns in neonates with hypoxic ischemic encephalopathy
12. Nociplastic pain: towards an understanding of prevalent pain conditions10.1016/S0140-6736(21)00392-5 ↗
13. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)10.7554/eLife.86002 ↗
14. McKenzie back exercises
15. Combined transplantation of hiPSC-NSC and hMSC ameliorated neuroinflammation and promoted neuroregeneration in acute spinal cord injury10.1186/s13287-024-03655-x ↗
16. The microbiota–gut–brain Axis in psychiatric disorders
18. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders10.1016/j.phrs.2021.105840 ↗
19. Brain–gut–microbiota axis in depression: a historical overview and future directions10.1016/j.brainresbull.2022.02.004 ↗
20. Obesity and gut–microbiota–brain axis: a narrative review10.1002/jcla.24420 ↗
21. The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids
22. Microbiota-derived metabolites as drivers of gut–brain communication10.1080/19490976.2022.2102878 ↗
23. Gut bacteria and neurotransmitters10.3390/microorganisms10091838 ↗
24. Short-chain fatty acids in diseases10.1186/s12964-023-01219-9 ↗
25. Dimethyl itaconate ameliorates cognitive impairment induced by a high-fat diet via the gut-brain axis in mice
26. Prebiotic inulin and sodium butyrate attenuate obesity-induced intestinal barrier dysfunction by induction of antimicrobial peptides10.3389/fimmu.2021.678360 ↗
27. Gut microbiota-derived metabolites mediate the neuroprotective effect of melatonin in cognitive impairment induced by sleep deprivation10.1186/s40168-022-01452-3 ↗
28. Sodium butyrate reduces overnutrition-induced microglial activation and hypothalamic inflammation10.1016/j.intimp.2022.109083 ↗
29. Beneficial effects of exogenous ketogenic supplements on aging processes and age-related neurodegenerative diseases10.3390/nu13072197 ↗
30. GABAB receptors in neurodegeneration10.1007/7854_2021_222 ↗
31. Glia: a major player in glutamate–GABA dysregulation‐mediated neurodegeneration10.1002/jnr.24977 ↗
32. Sodium butyrate in both prevention and supportive treatment of colorectal cancer10.3389/fcimb.2022.1023806 ↗
33. Gut-testis Axis: microbiota prime metabolome to increase sperm quality in young type 2 diabetes10.1128/spectrum.01423-22 ↗
34. Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell10.1080/19490976.2023.2249143 ↗
35. Costa · Food Chem. · 2021 · 36310.1016/j.foodchem.2021.130248 ↗
36. Application of nanotechnology in analysis and removal of heavy metals in food and water resources10.3390/nano11071792 ↗
37. Comparative evaluation of engineered polypeptide scaffolds in HER2-targeting magnetic nanocarrier delivery10.1021/acsomega.1c01811 ↗
38. Profibrotic role of transcription factor SP1 in cross-talk between fibroblasts and M2 macrophages10.1016/j.isci.2023.108484 ↗
39. Sp1-like protein KLF13 acts as a negative feedback regulator of TGF-β signaling and fibrosis10.1016/j.celrep.2023.112367 ↗
40. The oncogenic roles of JC polyomavirus in cancer10.3389/fonc.2022.976577 ↗
41. Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression10.1186/s12943-022-01547-3 ↗
42. Augmenter of liver regeneration: mitochondrial function and steatohepatitis10.1016/j.jhep.2022.06.019 ↗
43. Regulation of alternative polyadenylation by the C2H2-zinc-finger protein Sp110.1016/j.molcel.2022.06.031 ↗
44. Nonenzymatic function of DPP4 promotes diabetes-associated cognitive dysfunction through IGF-2R/PKA/SP1/ERp29/IP3R2 pathway-mediated impairment of Treg function and M1 microglia polarization10.1016/j.metabol.2022.155340 ↗
45. TRIM56 acts through the IQGAP1-CDC42 signaling axis to promote glioma cell migration and invasion
46. Construction of a novel immune-related prognostic-predicting model of gastric cancer10.1016/j.gene.2022.147032 ↗
47. Extracellular vesicles released by transforming growth factor-beta 1-preconditional mesenchymal stem cells promote recovery in mice with spinal cord injury
48. The role of transforming growth factor β1/Smad pathway in Alzheimer's disease inflammation pathology10.1007/s11033-022-07951-8 ↗
49. TGF-β1 signalling in Alzheimer's pathology and cytoskeletal reorganization: a specialized Tau perspective10.1186/s12974-023-02751-8 ↗
50. Reduced PLP2 expression increases ER-stress-induced neuronal apoptosis and risk for adverse neurological outcomes after hypoxia ischemia injury10.1093/hmg/ddv422 ↗
51. Diabetes drugs activate neuroprotective pathways in models of neonatal hypoxic-ischemic encephalopathy10.1038/s44321-024-00079-1 ↗
52. Mouse models of preterm birth: suggested assessment and reporting guidelines10.1093/biolre/ioy109 ↗
53. Neuroprotective effects of delayed TGF-β1 receptor antagonist administration on perinatal hypoxic-ischemic brain injury10.1159/000531650 ↗
54. Tumor targeting DVDMS-nanoliposomes for an enhanced sonodynamic therapy of gliomas10.1039/C8BM01187G ↗
55. Ultrasound facilitates naturally equipped exosomes derived from macrophages and blood serum for orthotopic glioma treatment10.1021/acsami.9b00893 ↗
56. Novel focused ultrasound gene therapy approach noninvasively restores dopaminergic neuron function in a rat Parkinson's disease model10.1021/acs.nanolett.7b00616 ↗
57. A preliminary study of Parkinson's gene therapy via sono-magnetic sensing gene vector for conquering extra/intracellular barriers in mice10.1016/j.brs.2020.02.024 ↗
58. Sodium butyrate-loaded nanoparticles coated with chitosan for the treatment of neovascularization in age-related macular degeneration: ocular biocompatibility and antiangiogenic activity10.1016/j.ejpb.2022.08.011 ↗
59. Amphotericin B-loaded Eudragit RL100 nanoparticles coated with hyaluronic acid for the treatment of vulvovaginal candidiasis10.1016/j.carbpol.2019.115608 ↗
60. Vancomycin-loaded N,N-dodecyl,methyl-polyethylenimine nanoparticles coated with hyaluronic acid to treat bacterial endophthalmitis: development, characterization, and ocular biocompatibility10.1016/j.ijbiomac.2020.12.057 ↗
61. Markery zapalenia, aktywacja płytek krwi i zaburzenia krzepnięcia w chorobach zapalnych jelit10.5604/17322693.1199305 ↗
62. Hypoxic ischemic encephalopathy (HIE) in term and preterm infants
63. Advances in neonatal acute kidney injury10.1542/peds.2021-051220 ↗
64. Neuroradiological mimics of periventricular leukomalacia10.1177/08830738211026052 ↗
65. Pharmacotherapy of psychomotor developmental delay in 6-12 months preterm infants with hypoxic-ischemic encephalopathy (the double-blind comparative multicenter placebo-controlled study)10.17116/jnevro201911910130 ↗
66. Stimuli‐responsive nanotechnology for RNA delivery10.1002/advs.202303597 ↗
67. Nanotechnology for cardiovascular diseases
68. Nano–bio interactions: biofilm‐targeted antibacterial nanomaterials
69. Cutting-edge nanotechnological approaches for lung cancer therapy10.2174/2589977514666220418085658 ↗
70. Advances in lung cancer treatment using nanomedicines10.1021/acsomega.2c04078 ↗
71. Riboflavin supplementation promotes butyrate production in the absence of gross compositional changes in the gut microbiota10.1089/ars.2022.0033 ↗
72. Sodium butyrate ameliorates high glucose-suppressed neuronal mitophagy by restoring PRKN expression via inhibiting the RELA-HDAC8 complex10.1080/15548627.2024.2323785 ↗
73. Low expression of the intestinal metabolite butyric acid and the corresponding memory pattern regulate HDAC4 to promote apoptosis in rat hippocampal neurons10.1016/j.ecoenv.2023.114660 ↗
74. Butyrate protects myenteric neurons loss in mice following experimental ulcerative colitis10.3390/cells12131672 ↗
75. Butyrate prevents the pathogenic anemia‐inflammation circuit by facilitating macrophage iron export10.1002/advs.202306571 ↗
76. Gut microbiome, prebiotics, intestinal permeability and diabetes complications10.1016/j.beem.2021.101507 ↗
77. Nicotinamide adenine dinucleotide treatment confers resistance to neonatal ischemia and hypoxia: effects on neurobehavioral phenotypes10.4103/NRR.NRR-D-23-01490 ↗
78. Inhibition of TLR4 prevents hippocampal hypoxic-ischemic injury by regulating ferroptosis in neonatal rats10.1016/j.expneurol.2021.113828 ↗
79. Protecting effects of 4-octyl itaconate on neonatal hypoxic-ischemic encephalopathy via Nrf2 pathway in astrocytes10.1186/s12974-024-03121-8 ↗
80. Construction of AC/DC magnetic syringe device for stimulated drug release, injection and ejection of nanocarriers and testing cytotoxicity in vitro10.1016/j.mex.2021.101312 ↗
81. From E-waste to high-value materials: sustainable synthesis of metal, metal Oxide, and MOF nanoparticles from waste printed circuit boards10.3390/nano14010069 ↗
82. An observational, multicenter, registry-based cohort study of Turkish Neonatal Society in neonates with Hypoxic ischemic encephalopathy10.1371/journal.pone.0295759 ↗